Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Clinical Utility of Overtube Use at the Time of Endoscopy (Spirus)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT00861263
First received: March 12, 2009
Last updated: March 7, 2014
Last verified: March 2014
Results First Received: November 12, 2013  
Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label
Condition: Small Bowel Visualization
Intervention: Device: overtube use during enteroscopy

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
We started this study in June 2007 and ended this study in Oct 2012. We approached any patient who was scheduled in our endoscopy suite for an overtube enteroscopy.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
The only significant event was that the subject was scheduled for an enteroscopy in our facility and a overtube was used at the time of endoscopy.

Reporting Groups
  Description
Enteroscopy Any subject who was referred for an enteroscopy to our facility and an overtube was used at the time of endoscopy was asked to participate in this study.

Participant Flow:   Overall Study
    Enteroscopy  
STARTED     193  
COMPLETED     193  
NOT COMPLETED     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Enteroscopy Any subject who was referred for an enteroscopy to our facility and an overtube was used at the time of endoscopy was asked to participate in this study.

Baseline Measures
    Enteroscopy  
Number of Participants  
[units: participants]
  193  
Age  
[units: participants]
 
<=18 years     0  
Between 18 and 65 years     94  
>=65 years     99  
Age  
[units: years]
Mean ± Standard Deviation
  62  ± 10  
Gender  
[units: participants]
 
Female     101  
Male     92  
Region of Enrollment  
[units: participants]
 
United States     193  



  Outcome Measures

1.  Primary:   Number of Patients With Persistent or Recurrent Bleeding   [ Time Frame: up to 6 yrs after after the endoscopy ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No limitations were found


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Dr. Peter Draganov MD
Organization: University of FLorida
phone: 352-273-9472
e-mail: peter.draganov@medicine.ufl.edu


No publications provided by University of Florida

Publications automatically indexed to this study:

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT00861263     History of Changes
Other Study ID Numbers: Spirus Overtube
Study First Received: March 12, 2009
Results First Received: November 12, 2013
Last Updated: March 7, 2014
Health Authority: United States: Institutional Review Board